Maribavir Impurity 10
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

142356-40-9Maribavir Impurity 10

● Auf Lager

Katalog-Nr.::VE0028062
CAS-Nr.::142356-40-9
Summenformel::C7H3BrCl2N2
Molare Masse::265.92 g/mol

Zusätzliche Informationen zu CAS 142356-40-9

Parent drug

Maribavir

IUPAC-Name

2-Bromo-5,6-dichloro-1H-benzo[d]imidazole

Pharmacopeial Synonyms

N/A

Synonyme

N/A

SMILES

ClC1=C(Cl)C=C2C(NC(Br)=N2)=C1

InChI

InChI=1S/C7H3BrCl2N2/c8-7-11-5-1-3(9)4(10)2-6(5)12-7/h1-2H,(H,11,12)

Beschreibung

Maribavir Impurity 10 (CAS 142356-40-9) is a synthesis-related contaminant monitored for its effect on drug substance quality and stability. This impurity exhibits distinctive chromatographic retention and mass spectral fragments that facilitate detection by HPLC-PDA and LC-MS/MS. Formation pathways indicate susceptibility to hydrolytic and oxidative conditions during intermediate processing, making process parameter control and in-process sampling critical. Robust analytical methods, validated limits and forced-degradation studies are recommended to define acceptable levels and support regulatory filings. Characterizing its physicochemical properties enables targeted mitigation strategies in route optimization and ensures consistent impurity profiling for quality assurance.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url